Tag Spinoffs
New imager identifies tissue types during surgery
UW-Madison spinoff company OnLume is continuing to develop its system for identifying tissue types during surgery. The company’s technology causes chemical labels to glow in the operating room.
Madison startup completing 100 solar setups in rural Africa
If you take electric lighting for granted, you have not lived in the Democratic Republic of Congo, where lighting options often come down to kerosene, candles or flashlights. The company's solar lights are a new choice.
Still on stage after 40 years: Wisconsin firm grows beyond theater lighting
Electronic Theatre Controls, started in 1974 by four UW–Madison undergraduates, has built its success on a programmable electronic control for stage lighting.
UW–Madison serial innovator Jack Ma cites collaboration as key to his success
Engineering Professor Jack Ma has more than 40 patents, more than 470 published papers and a half-dozen national professional fellowships.
Seeking grocery shopper loyalty, Fetch Rewards is “obsessed with simple”
A company started by a UW–Madison undergrad five years ago is finding success with an app that rewards grocery buyers who scan in their receipts.
UW startup’s invention featured at Paris fashion-tech show
The wearable system developed by Torq Labs is designed to help runners avoid injury by tracking leg movement with wireless sensors that transmit data to a smartphone app.
The doc sets the goal, then ‘Digital Intern’ goes to work
A UW–Madison spinoff company is refining a medical management software package designed to help doctors treat patients more efficiently.
Bringing cheap and accurate tuberculosis tests to Africa
Researchers are developing a "robust, simple and inexpensive way to increase the sensitivity of an existing TB test" by integrating a step very similar to a pregnancy test.
As influenza looms, Madison firm advances human trials of revolutionary vaccine
One of the most promising universal flu vaccines is being developed by FluGen, a spinoff from the University of Wisconsin–Madison. Next up is an experimental trial.
App software firm with UW–Madison roots starts selling “pro” version
“We are uniquely positioned to help teams build apps with the same exact code that will work on the web, and on the App Store and Google Play,” Ionic CEO Max Lynch says.
WARF program leader: Sale marks success for UW–Madison research prowess, creativity
The Accelerator Program represents a broadening of WARF’s original role, as it as recognized the need to guide and encourage start-up companies, and invest in them.
Center for Dairy Research helps entrepreneur create snack bar for young women
A new line of dairy-based snack bars developed to promote healthy eating and a healthy self-image among young women were created by a UW–Madison alumnus with help from UW–Madison’s Center for Dairy Research (CDR).
UW–Madison’s D2P Igniter program seeks next round of entrepreneurs
Igniter has helped in the creation of 17 startup companies based on UW–Madison discoveries over the past three years.
Waisman Biomanufacturing has new managing director
Carl Ross has more than 26 years of experience advancing a wide range of cell and gene therapies, vaccines and therapeutic proteins into human clinical trials.
Director leaving after helping UW innovators bring ideas to market
“I spent three years getting D2P going, and we did some good things in commercializing innovation from campus,” John Biondi says. “Now it’s time to turn it over to someone else who can take it to the next level.”
New measure of insulin-making cells could gauge diabetes progression, treatment
Researchers at the University of Wisconsin–Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.
Biondi departs D2P to grow his cider venture
Discovery to Product (D2P) staff have mentored UW–Madison students, staff and faculty towards successful technology commercialization, including patenting, partnership with industry, and new company formation.
Made-in-Madison skin replacement starts final clinical trial
A University of Wisconsin–Madison spinoff that makes an innovative material designed to speed healing of serious burns has begun a large clinical trial for the “regenerative skin tissue” it has been developing since 2000.